N. Thatcher - Concepedia

Author

N. Thatcher

The Christie Hospital

Also Known As

N M Thatcher, N THATCHER, N Thatcher, N. M. Thatcher, N. Thatcher, N.M. Thatcher, Nick Thatcher, Thatcher, N.

230

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

The Christie Hospital Cancer Research UK Manchester Institute Wythenshawe Hospital University of Manchester Cancer Research UK

About

N. Thatcher is an author at The Christie Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	58	2.9K
2	Health Sciences	11	12	417
3	Engineering	1	1	10
4	Natural Sciences	1	1	84
5	Public Health	1	1	111

N. Thatcher

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson, Journal of Clinical Oncology	2000	1.3K
Alternate splicing produces a novel cyclin D1 transcript. DC Betticher, N. Thatcher, H. J. Altermatt, PubMed	1995	399
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. Heather Anderson, Birthe Lund, Flemming W. Bach, Journal of Clinical Oncology	1994	376
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. N. M. Bleehen, E.S. Newlands, Siow Ming Lee, Journal of Clinical Oncology	1995	282
Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma B. W. Hancock, Keith Wheatley, SyedHasan Harris, Journal of Clinical Oncology	2003	223
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer Daniel Betticher, Jim Heighway, P S Hasleton, British Journal of Cancer Tumor BiologyOncologyNon-small-cell Lung CancerCyclin D1Medicine	1996	219
Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients T. Cerny, H. Anderson, V H Bramwell, International Journal of Cancer	1987	206
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients MH Bronchud, MR Potter, G.R. Morgenstern, British Journal of Cancer InflammationTranslational MedicineVivo AnalysisGranulocyteStem Cell Mobilization	1988	187
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. William P. Steward, Joachim von Pawel, U. Gatzemeier, Journal of Clinical Oncology	1998	147
Expression of epidermal growth factor receptor (EGF-R) in human lung tumours Thomas Cerny, D M Barnes, P S Hasleton, British Journal of Cancer Tumor BiologyMedicinePathologyEpithelial-mesenchymal InteractionsHuman Lung Tumours	1986	143

Page 1